STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$32.06 USD
-0.06 (-0.19%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $32.04 -0.02 (-0.06%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$32.06 USD
-0.06 (-0.19%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $32.04 -0.02 (-0.06%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Zacks News
Ecolab to Boost Food Safety Standards With Holchem Buyout
by Zacks Equity Research
Ecolab (ECL) to benefit from Holchem Group's unique offerings for the food and beverage, foodservice and hospitality industries.
Here's Why Investors Should Hold AngioDynamics Stock Now
by Zacks Equity Research
AngioDynamics' (ANGO) gains from solid prospects in the NanoKnife platform. However, sluggishness in the Venous Insufficiency business is a headwind.
Veeva Systems Announces New DAM Solution for Life Sciences
by Zacks Equity Research
Veeva Vault Digital Publishing uses Veeva Systems' (VEEV) flagship Vault PromoMats or Vault MedComms platforms for updating digital content. The platform leverages on Amazon CloudFront.
Here's Why You Should Hold Pacific Biosciences (PACB) Now
by Zacks Equity Research
Pacific Biosciences (PACB) is likely to gain from strong prospects in the Sequel System platform. However, the company faces cutthroat competition in the DNA sequencing market.
Here's Why You Should Invest in Accuray (ARAY) Stock Now
by Zacks Equity Research
Accuray's (ARAY) benefits from growing adoption of non-surgical treatment options among cancer patients and increasing demand for its latest offerings.
Ecolab to Buy Bioquell for Healthcare & Life Sciences' Growth
by Zacks Equity Research
Ecolab (ECL) to leverage on Bioquell's innovative bio-decontamination and isolator platforms for residue-free surface decontamination.
Cardinal Health to Highlight Cost-Control Approach in ASHP
by Zacks Equity Research
Cardinal Health (CAH) helps hospitals identify hidden savings, improve patient outcomes and drive supply chain efficiencies.
Here's Why Investors Should Hold Medidata (MDSO) Stock Now
by Zacks Equity Research
Solid prospects in the Rave Genomics platform are likely to provide Medidata (MDSO) a competitive edge in the MedTech space.
Merit Medical (MMSI) Completes Cianna Medical Acquisition
by Zacks Equity Research
Merit Medical (MMSI) is likely to gain traction in the global breast lesion localization market, courtesy of the Cianna Medical acquisition.
Zacks.com featured highlights include: K12, Great Lakes Dredge, Luxfer, Integer Holdings and STAAR
by Zacks Equity Research
Zacks.com featured highlights include: K12, Great Lakes Dredge, Luxfer, Integer Holdings and STAAR
Zacks.com featured highlights include: WNS, Attunity, Middlesex, STAAR and Materialise
by Zacks Equity Research
Zacks.com featured highlights include: WNS, Attunity, Middlesex, STAAR and Materialise
Tap These 5 Profitable Stocks With Enticing Net Income Ratio
by Zacks Equity Research
Net income ratio gives us the exact profit level of a company
5 Stocks With Recent Price Strength to Maximize Your Gains
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Staar Surgical (STAA) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Staar Surgical (STAA) delivered earnings and revenue surprises of 333.33% and 5.55%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Robust ICL Sales Aid STAAR Surgical (STAA) Q3 Earnings?
by Zacks Equity Research
STAAR Surgical (STAA) is expected to pitch in a solid top-line contribution with its Implantable Collamer Lens (ICL) consisting of the EVO Visian ICL product line.
Zacks.com highlights: Champions Oncology, STAAR Surgical, Boingo Wireless, Verso and BioSpecifics Technologies
by Zacks Equity Research
Zacks.com highlights: Champions Oncology, STAAR Surgical, Boingo Wireless, Verso and BioSpecifics Technologies
5 Stocks With Recent Price Strength to Strengthen Portfolio
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Can the Rally in STAAR Surgical (STAA) Shares Continue?
by Zacks Equity Research
STAAR Surgical Company (STAA) has been on the move lately as the stock has risen by 22.7% in the past four weeks, and it is currently trading well above its 20-Day SMA.
Zacks.com highlights: PCM, STAAR Surgical, Verso, Johnson Outdoors and BioSpecifics Technologies
by Zacks Equity Research
Zacks.com highlights: PCM, STAAR Surgical, Verso, Johnson Outdoors and BioSpecifics Technologies
5 Stocks With Recent Price Strength to Enhance Your Returns
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
STAAR Surgical (STAA) Looks Good: Stock Adds 9.2% in Session
by Zacks Equity Research
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise over 9% on the day.
The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew
STAAR Surgical (STAA) Catches Eye: Stock Moves 8.3% Higher
by Zacks Equity Research
STAAR Surgical Company (STAA) moved big last session, as its shares jumped over 8% on the day.